SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Arseniy E. Yuzhalin, Anton G. Kutikhin, Interleukins in Cancer Biology, 2015,

    CrossRef

  2. 2
    Paula Renata Lima Machado, Kleber Juvenal Silva Farias, Julieta Genre, Carlo José Freire Oliveira, Paulo Marcos Matta Guedes, Benedito Antônio Lopes da Fonseca, Disseminated Kaposi's Sarcoma in Patients with HIV Infection Correlates to High Serum Levels of IL-10, Viral Immunology, 2014, 27, 7, 356

    CrossRef

  3. 3
    Rozita Roshani, Fiona McCarthy, Thorsten Hagemann, Inflammatory cytokines in human pancreatic cancer, Cancer Letters, 2014, 345, 2, 157

    CrossRef

  4. 4
    Poonam Gaur, Avadhesh Kumar Singh, Nootan K. Shukla, Satya N. Das, Inter-relation of Th1, Th2, Th17 and Treg cytokines in oral cancer patients and their clinical significance, Human Immunology, 2014, 75, 4, 330

    CrossRef

  5. 5
    Marina Lesina, Sonja Maria Wörmann, Patrick Neuhöfer, Liang Song, Hana Algül, Interleukin-6 in inflammatory and malignant diseases of the pancreas, Seminars in Immunology, 2014, 26, 1, 80

    CrossRef

  6. 6
    Reinhild Holmer, Freya A Goumas, Georg H Waetzig, Stefan Rose-John, Holger Kalthoff, Interleukin-6: a villain in the drama of pancreatic cancer development and progression, Hepatobiliary & Pancreatic Diseases International, 2014, 13, 4, 371

    CrossRef

  7. 7
    Kathryn Middleton, Joanna Jones, Zarnie Lwin, Jermaine I.G. Coward, Interleukin-6: An angiogenic target in solid tumours, Critical Reviews in Oncology/Hematology, 2014, 89, 1, 129

    CrossRef

  8. 8
    T. Dragovich, D. Laheru, F. Dayyani, V. Bolejack, L. Smith, J. Seng, H. Burris, P. Rosen, M. Hidalgo, P. Ritch, A. F. Baker, N. Raghunand, J. Crowley, D. D. Von Hoff, Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001), Cancer Chemotherapy and Pharmacology, 2014, 74, 2, 379

    CrossRef

  9. 9
    Laura Visconti, Katherine Nelissen, Laura Deckx, Marjan van den Akker, Wim Adriaensen, Liesbeth Daniels, Cathy Matheï, Loes Linsen, Niels Hellings, Piet Stinissen, Frank Buntinx, Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients, Biomarkers in Medicine, 2014, 8, 2, 297

    CrossRef

  10. 10
    Naoki Fujitsuka, Yasuhito Uezono, Rikkunshito, a ghrelin potentiator, ameliorates anorexia–cachexia syndrome, Frontiers in Pharmacology, 2014, 5,

    CrossRef

  11. 11
    Victoria E Shaw, Brian Lane, Claire Jenkinson, Trevor Cox, William Greenhalf, Christopher M Halloran, Joseph Tang, Robert Sutton, John P Neoptolemos, Eithne Costello, Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease, Molecular Cancer, 2014, 13, 1, 114

    CrossRef

  12. 12
    Xin Yao, Jiaqi Huang, Haihong Zhong, Nan Shen, Raffaella Faggioni, Michael Fung, Yihong Yao, Targeting interleukin-6 in inflammatory autoimmune diseases and cancers, Pharmacology & Therapeutics, 2014, 141, 2, 125

    CrossRef

  13. 13
    S M Wörmann, K N Diakopoulos, M Lesina, H Algül, The immune network in pancreatic cancer development and progression, Oncogene, 2014, 33, 23, 2956

    CrossRef

  14. 14
    Emelie Karnevi, Roland Andersson, Ann H Rosendahl, Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion, Immunology and Cell Biology, 2014, 92, 6, 543

    CrossRef

  15. 15
    Minoti V. Apte, Jeremy S. Wilson, Aurelia Lugea, Stephen J. Pandol, A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment, Gastroenterology, 2013, 144, 6, 1210

    CrossRef

  16. 16
    Simon M. Denley, Nigel B. Jamieson, Pamela McCall, Karin A. Oien, Jennifer P. Morton, C. Ross Carter, Joanne Edwards, Colin J. McKay, Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma, Journal of Gastrointestinal Surgery, 2013, 17, 5, 887

    CrossRef

  17. 17
    S Kondo, H Ueno, H Hosoi, J Hashimoto, C Morizane, F Koizumi, K Tamura, T Okusaka, Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma, British Journal of Cancer, 2013, 109, 3, 739

    CrossRef

  18. You have free access to this content18
    Hye Won Chung, Sunphil Jang, Jong-Baeck Lim, Clinical implications and diagnostic usefulness of correlation between soluble major histocompatibility complex class I chain-related molecule a and protumorigenic cytokines in pancreatic ductal adenocarcinoma, Cancer, 2013, 119, 1
  19. 19
    Ewa Bien, Malgorzata Krawczyk, Ewa Izycka-Swieszewska, Piotr Trzonkowski, Bernarda Kazanowska, Elzbieta Adamkiewicz-Drozynska, Anna Balcerska, Deregulated systemic IL-10/IL-12 balance in advanced and poor prognosis paediatric soft tissue sarcomas, Biomarkers, 2013, 18, 3, 204

    CrossRef

  20. 20
    Jesse Hinton, Richard Callan, Charlie Bodine, Wayne Glasgow, Steve Brower, Shi-Wen Jiang, Jinping Li, Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas, Expert Review of Molecular Diagnostics, 2013, 13, 5, 431

    CrossRef

  21. 21
    S Mitsunaga, M Ikeda, S Shimizu, I Ohno, J Furuse, M Inagaki, S Higashi, H Kato, K Terao, A Ochiai, Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer, British Journal of Cancer, 2013, 108, 10, 2063

    CrossRef

  22. 22
    Kaye M. Reid-Lombardo, Brooke L. Fridley, William R. Bamlet, Julie M. Cunningham, Michael G. Sarr, Gloria M. Petersen, Survival Is Associated With Genetic Variation in Inflammatory Pathway Genes Among Patients With Resected and Unresected Pancreatic Cancer, Annals of Surgery, 2013, 257, 6, 1096

    CrossRef

  23. 23
    Amanda M. Guth, Steven Dow, Withrow and MacEwen's Small Animal Clinical Oncology, 2013,

    CrossRef

  24. 24
    Marilia Seelaender, Miguel Batista, Fabio Lira, Renata Silverio, Filippo Rossi-Fanelli, Inflammation in cancer cachexia: To resolve or not to resolve (is that the question?), Clinical Nutrition, 2012, 31, 4, 562

    CrossRef

  25. 25
    V A Grote, R Kaaks, A Nieters, A Tjønneland, J Halkjær, K Overvad, M R Skjelbo Nielsen, M C Boutron-Ruault, F Clavel-Chapelon, A Racine, B Teucher, S Becker, T Pischon, H Boeing, A Trichopoulou, C Cassapa, V Stratigakou, D Palli, V Krogh, R Tumino, P Vineis, S Panico, L Rodríguez, E J Duell, M-J Sánchez, M Dorronsoro, C Navarro, A B Gurrea, P D Siersema, P HM Peeters, W Ye, M Sund, B Lindkvist, D Johansen, K-T Khaw, N Wareham, N E Allen, R C Travis, V Fedirko, M Jenab, D S Michaud, S-C Chuang, D Romaguera, H B Bueno-de-Mesquita, S Rohrmann, Inflammation marker and risk of pancreatic cancer: a nested case–control study within the EPIC cohort, British Journal of Cancer, 2012,

    CrossRef

  26. 26
    Maja Cigrovski Berković, Tina Catela Ivković, Jasminka Marout, Vanja Zjačić-Rotkvić, Sanja Kapitanović, Interleukin 1β Gene Single-Nucleotide Polymorphisms and Susceptibility to Pancreatic Neuroendocrine Tumors, DNA and Cell Biology, 2012, 31, 4, 531

    CrossRef

  27. 27
    H. Sakamoto, H. Kimura, M. Sekijima, K. Matsumoto, T. Arao, T. Chikugo, Y. Yamada, M. Kitano, A. Ito, Y. Takeyama, M. Kudo, K. Nishio, Plasma Concentrations of Angiogenesis-related Molecules in Patients with Pancreatic Cancer, Japanese Journal of Clinical Oncology, 2012, 42, 2, 105

    CrossRef

  28. 28
    Bilal Bin Hafeez, Mohammad Sarwar Jamal, Joseph W. Fischer, Ala Mustafa, Ajit Kumar Verma, Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways, International Journal of Cancer, 2012, 131, 9
  29. 29
    Umut Demirci, Melek Yaman, Suleyman Buyukberber, Ugur Coskun, Meltem Baykara, Kadriye Uslu, Ahmet Ozet, Mustafa Benekli, E. Umit Bagriacik, Prognostic importance of markers for inflammation, angiogenesis and apoptosis in high grade glial tumors during temozolomide and radiotherapy, International Immunopharmacology, 2012, 14, 4, 546

    CrossRef

  30. 30
    Takeshi Ishikawa, Satoshi Kokura, Naoyuki Sakamoto, Manabu Okajima, Tatsuzo Matsuyama, Hiromi Sakai, Yoko Okumura, Satoko Adachi, Naohisa Yoshida, Kazuhiko Uchiyama, Osamu Handa, Tomohisa Takagi, Hideyuki Konishi, Naoki Wakabayashi, Nobuaki Yagi, Takashi Ando, Kazuko Uno, Yuji Naito, Toshikazu Yoshikawa, Relationship between circulating cytokine levels and physical or psychological functioning in patients with advanced cancer, Clinical Biochemistry, 2012, 45, 3, 207

    CrossRef

  31. 31
    David Blum, Aurelius Omlin, Vickie E. Baracos, Tora S. Solheim, Benjamin H.L. Tan, Patrick Stone, Stein Kaasa, Ken Fearon, Florian Strasser, Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer, Critical Reviews in Oncology/Hematology, 2011, 80, 1, 114

    CrossRef

  32. 32
    Martin Loos, Rupert Langer, Tibor Schuster, Ralf Gertler, Axel Walch, Sandra Rauser, Helmut Friess, Marcus Feith, Clinical Significance of the Costimulatory Molecule B7-H1 in Barrett Carcinoma, The Annals of Thoracic Surgery, 2011, 91, 4, 1025

    CrossRef

  33. 33
    Nuh N. Rahbari, Christoph Reissfelder, Monika Mühlbayer, Kathrin Weidmann, Christoph Kahlert, Markus W. Büchler, Jürgen Weitz, Moritz Koch, Correlation of Circulating Angiogenic Factors with Circulating Tumor Cells and Disease Recurrence in Patients Undergoing Curative Resection for Colorectal Liver Metastases, Annals of Surgical Oncology, 2011, 18, 8, 2182

    CrossRef

  34. 34
    Laura K. Aguilar, Brian W. Guzik, Estuardo Aguilar-Cordova, Cytotoxic immunotherapy strategies for cancer: Mechanisms and clinical development, Journal of Cellular Biochemistry, 2011, 112, 8
  35. 35
    Claudia M. Monroy, Andrea C. Cortes, Mirtha S. Lopez, Anthony M. D'Amelio, Carol J. Etzel, Anas Younes, Sara S. Strom, Randa A. El-Zein, Hodgkin disease risk: Role of genetic polymorphisms and gene–gene interactions in inflammation pathway genes, Molecular Carcinogenesis, 2011, 50, 1
  36. 36
    Helena Kiefel, Marco Pfeifer, Sandra Bondong, John Hazin, Peter Altevogt, Linking L1CAM-mediated signaling to NF-κB activation, Trends in Molecular Medicine, 2011, 17, 4, 178

    CrossRef

  37. 37
    U. Bharadwaj, C. Marin-Muller, M. Li, C. Chen, Q. Yao, Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation, Carcinogenesis, 2011, 32, 7, 1013

    CrossRef

  38. 38
    Basit Saleem Qazi, Kai Tang, Asma Qazi, Recent Advances in Underlying Pathologies Provide Insight into Interleukin-8 Expression-Mediated Inflammation and Angiogenesis, International Journal of Inflammation, 2011, 2011, 1

    CrossRef

  39. 39
    Marina Lesina, Magdalena U. Kurkowski, Katharina Ludes, Stefan Rose-John, Matthias Treiber, Günter Klöppel, Akihiko Yoshimura, Wolfgang Reindl, Bence Sipos, Shizuo Akira, Roland M. Schmid, Hana Algül, Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer, Cancer Cell, 2011, 19, 4, 456

    CrossRef

  40. 40
    Michael J Tisdale, Are tumoral factors responsible for host tissue wasting in cancer cachexia?, Future Oncology, 2010, 6, 4, 503

    CrossRef

  41. 41
    Uwe D. Rohr, Anca G. Gocan, Doris Bachg, Adolf E. Schindler, Cancer protection of soy resembles cancer protection during pregnancy, Hormone Molecular Biology and Clinical Investigation, 2010, 3, 2

    CrossRef

  42. 42
    Jennifer Wheler, Apostolia M. Tsimberidou, Stacy Moulder, Massimo Cristofanilli, David Hong, Aung Naing, Raminder Pathak, Suyu Liu, Lei Feng, Razelle Kurzrock, Clinical Outcomes of Patients With Breast Cancer in a Phase I Clinic: The M. D. Anderson Cancer Center Experience, Clinical Breast Cancer, 2010, 10, 1, 46

    CrossRef

  43. 43
    A. Bartosch-Härlid, R. Andersson, Diabetes Mellitus in Pancreatic Cancer and the Need for Diagnosis of Asymptomatic Disease, Pancreatology, 2010, 10, 4, 423

    CrossRef

  44. 44
    Barbara Mroczko, Magdalena Groblewska, Mariusz Gryko, Bogusław Kędra, Maciej Szmitkowski, Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis, Journal of Clinical Laboratory Analysis, 2010, 24, 4
  45. 45
    HQ Ouyang, Effects of Qingyi Huaji decoction on serum levels of interleukin-6, interleukin-8 and tumor necrosis factor-α in nude mice bearing pancreatic tumors, Journal of Chinese Integrative Medicine, 2010, 8, 7, 655

    CrossRef

  46. 46
    M M Moore, W Chua, K A Charles, S J Clarke, Inflammation and Cancer: Causes and Consequences, Clinical Pharmacology & Therapeutics, 2010, 87, 4, 504

    CrossRef

  47. 47
    A. J. Schetter, N. H. H. Heegaard, C. C. Harris, Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways, Carcinogenesis, 2010, 31, 1, 37

    CrossRef

  48. 48
    Yuji Toiyama, Chikao Miki, Yasuhiro Inoue, Sayaka Minobe, Hiroko Urano, Masato Kusunoki, Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma, Surgery Today, 2010, 40, 1, 46

    CrossRef

  49. 49
    S. Herzig, Molekulare und metabolische Komponenten der Tumorkachexie, Der Gynäkologe, 2010, 43, 7, 559

    CrossRef

  50. 50
    Farah Hussain, Jayson Wang, Raida Ahmed, Stephanie K. Guest, Eric W.-F. Lam, Gordon Stamp, Mona El-Bahrawy, The expression of IL-8 and IL-8 receptors in pancreatic adenocarcinomas and pancreatic neuroendocrine tumours, Cytokine, 2010, 49, 2, 134

    CrossRef

  51. 51
    Charles A. Dinarello, Why not treat human cancer with interleukin-1 blockade?, Cancer and Metastasis Reviews, 2010, 29, 2, 317

    CrossRef

  52. 52
    A. Bartosch-Härlid, R. Andersson, Cachexia in pancreatic cancer – Mechanisms and potential intervention, e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 2009, 4, 6, e337

    CrossRef

  53. 53
    Renata Talar-Wojnarowska, Anita Gasiorowska, Beata Smolarz, Hanna Romanowicz-Makowska, Andrzej Kulig, Ewa Malecka-Panas, Clinical Significance of Interleukin-6 (Il-6) Gene Polymorphism and Il-6 Serum Level in Pancreatic Adenocarcinoma and Chronic Pancreatitis, Digestive Diseases and Sciences, 2009, 54, 3, 683

    CrossRef

  54. 54
    K. M. O'Hayer, D. C. Brady, C. M. Counter, ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis, Carcinogenesis, 2009, 30, 11, 1841

    CrossRef

  55. 55
    Cielito C. Reyes-Gibby, Sanjay Shete, Sriram Yennurajalingam, Marsha Frazier, Eduardo Bruera, Razelle Kurzrock, Christopher H. Crane, James Abbruzzese, Douglas Evans, Margaret R. Spitz, Genetic and Nongenetic Covariates of Pain Severity in Patients with Adenocarcinoma of the Pancreas: Assessing the Influence of Cytokine Genes, Journal of Pain and Symptom Management, 2009, 38, 6, 894

    CrossRef

  56. 56
    Norifumi Harimoto, Ken Shirabe, Tomoyuki Abe, Kiyoshi Kajiyama, Takashi Nagaie, Tomonobu Gion, Yousuke Kuroda, Yoshihiko Maehara, Interleukin-8 Producing Hepatocellular Carcinoma with Pyrexia, HPB Surgery, 2009, 2009, 1

    CrossRef

  57. 57
    Ewa Bien, Anna Balcerska, Elzbieta Adamkiewicz-Drozynska, Malgorzata Rapala, Malgorzata Krawczyk, Jan Stepinski, Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias, Clinical Biochemistry, 2009, 42, 10-11, 1144

    CrossRef

  58. 58
    William S. Breitbart, Yesne Alici, Psycho-Oncology, Harvard Review of Psychiatry, 2009, 17, 6, 361

    CrossRef

  59. 59
    Andrada Seicean, Daniel Popa, Teodora Mocan, Victor Cristea, Ioana Neagoe, Th1 and Th2 Profiles in Patients With Pancreatic Cancer Compared With Chronic Pancreatitis, Pancreas, 2009, 38, 5, 594

    CrossRef

  60. 60
    F Graziano, A Ruzzo, E Canestrari, F Loupakis, D Santini, E Rulli, B Humar, N Galluccio, R Bisonni, I Floriani, P Maltese, A Falcone, G Tonini, V Catalano, A Fontana, L Giustini, G Masi, B Vincenzi, P Alessandroni, M Magnani, Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer, The Pharmacogenomics Journal, 2009, 9, 1, 78

    CrossRef

  61. 61
    Fritz Stiefel, Daniele Stagno, Textbook of Palliative Medicine, 2009,

    CrossRef

  62. 62
    Michael J Tisdale, Catabolic mediators of cancer cachexia, Current Opinion in Supportive and Palliative Care, 2008, 2, 4, 256

    CrossRef

  63. 63
    Martin Loos, Nathalia A. Giese, Jörg Kleeff, Thomas Giese, Matthias M. Gaida, Frank Bergmann, Melanie Laschinger, Markus W.Büchler, Helmut Friess, Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer, Cancer Letters, 2008, 268, 1, 98

    CrossRef

  64. 64
    Bostjan Seruga, Haibo Zhang, Lori J. Bernstein, Ian F. Tannock, Cytokines and their relationship to the symptoms and outcome of cancer, Nature Reviews Cancer, 2008, 8, 11, 887

    CrossRef

  65. 65
    Vilma Oliveira Frick, Claudia Rubie, Mathias Wagner, Stefan Graeber, Henner Grimm, Berit Kopp, Bettina M. Rau, Martin K. Schilling, Enhanced ENA-78 and IL-8 Expression in Patients with Malignant Pancreatic Diseases, Pancreatology, 2008, 8, 4-5, 488

    CrossRef

  66. 66
    Klaus K.A. Witte, Sarah J. Ford, Tom Preston, John D. Parker, Andrew L. Clark, Fibrinogen synthesis is increased in cachectic patients with chronic heart failure, International Journal of Cardiology, 2008, 129, 3, 363

    CrossRef

  67. 67
    Min Li, Yuqing Zhang, Louis W. Feurino, Hao Wang, William E. Fisher, F. Charles Brunicardi, Changyi Chen, Qizhi Yao, Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer, Cancer Science, 2008, 99, 4
  68. 68
    Andrew A. Gumbs, Obesity, Pancreatitis, and Pancreatic Cancer, Obesity Surgery, 2008, 18, 9, 1183

    CrossRef

  69. 69
    Michael J. Tisdale, Abeloff's Clinical Oncology, 2008,

    CrossRef

  70. 70
    O.M. Ahmed ., R.G. Ahmed ., M.M.S. Nada ., M. Bahgat ., Does the Heat Stress Affect the Neurons Development in Some Central Nervous System Regions of Albino Rat Newborns?, Asian Journal of Animal and Veterinary Advances, 2007, 2, 3, 86

    CrossRef

  71. 71
    Malgorzata Krzystek-Korpacka, Malgorzata Matusiewicz, Dorota Diakowska, Krzysztof Grabowski, Katarzyna Blachut, Irena Kustrzeba-Wojcicka, Teresa Banas, Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-α, VEGF-A, VEGF–C and midkine in gastroesophageal cancer patients, Clinical Biochemistry, 2007, 40, 18, 1353

    CrossRef

  72. 72
    David S. Hong, Laura S. Angelo, Razelle Kurzrock, Interleukin-6 and its receptor in cancer, Cancer, 2007, 110, 9
  73. 73
    Birgitta Clinchy, Annelie Fransson, Bengt Druvefors, Anna Hellsten, Annika Håkansson, Bertil Gustafsson, Rune Sjödahl, Leif Håkansson, Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma, Cancer, 2007, 109, 9
  74. 74
    Kyung W. Noh, Surakit Pungpapong, Michael B. Wallace, Timothy A. Woodward, Massimo Raimondo, Do Cytokine Concentrations in Pancreatic Juice Predict the Presence of Pancreatic Diseases?, Clinical Gastroenterology and Hepatology, 2006, 4, 6, 782

    CrossRef

  75. 75
    Stefan Boeck, Petra Stieber, Stefan Holdenrieder, Ralf Wilkowski, Volker Heinemann, Prognostic and Therapeutic Significance of Carbohydrate Antigen 19-9 as Tumor Marker in Patients with Pancreatic Cancer, Oncology, 2006, 70, 4, 255

    CrossRef

  76. 76
    Shuichi Mitsunaga, Takahiro Hasebe, Motoki Iwasaki, Taira Kinoshita, Atsushi Ochiai, Nobuyoshi Shimizu, Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas, Cancer Science, 2005, 96, 12